---
layout: post
title: Will experience support use of first-ever retinal gene therapy?
original_url: https://www.ophthalmologytimes.com/view/will-experience-support-use-of-first-ever-retinal-gene-therapy-
abstract: New gene therapies such as these raise the hope of treating a previously incurable disease with a favorable adverse effect profile. However, as with any new therapeutic product, there are limited real-world data, so it is natural that uncertainties regarding the durability and benefit-risk ratio exist.
notes: Targets RPE65 with therapy but seems to cause atrophy. Good news, bad news?
tags:
  - RPE65
  - gene therapy
  - LCA
  - academic
---
